Résultats de la recherche - C. Chouaïd
- Résultat(s) 1 - 20 résultats de 48
- Aller à la page suivante
-
1
-
2
-
3
-
4
-
5
-
6
Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study par Laurent Laforest, Nicolás Roche, Gilles Devouassoux, Manon Belhassen, C. Chouaïd, M. Ginoux, Éric Van Ganse
Publié 2016Artigo -
7
-
8
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-smal... par C. Chouaïd, L. Bensimon, E. Clay, A. Millier, L. Lévy-Bachelot, Min Huang, Pierre Lévy
Publié 2018Artigo -
9
Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection par Joël Gozlan, J.‐M. Salord, C. Chouaïd, Claudine Duvivier, O Picard, Marie‐Caroline Meyohas, Jean‐Claude Petit
Publié 1993Artigo -
10
-
11
-
12
Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment par H. Picchi, Christine Mateus, C. Chouaïd, Benjamin Besse, Aurélien Marabelle, Jean‐Marie Michot, Stéphane Champiat, Anne-Laure Voisin, Olivier Lambotte
Publié 2017Editorial -
13
The association between asthma control, health care costs, and quality of life in France and Spain par Marianne Doz, C. Chouaïd, Laure Com-Ruelle, Eduardo Calvo, Max Brosa, J. Robert, L. Decuypère, C. Pribil, Alicia Huerta, B. Detournay
Publié 2013Artigo -
14
Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis par Thierry Landre, Abdoulaye Karaboué, Zachary S. Buchwald, Pasquale F. Innominato, David C. Qian, Jean‐Baptiste Assié, C. Chouaïd, Françis Lévi, Boris Duchemann
Publié 2024Revisão -
15
Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain par Michel Maira, Christian Schnell, Pier‐Luigi Lollini, C. Chouaïd, Peter Schmid, Paolo Nanni, Dawn Lam, Emmanuelle di Tomaso, Cristian Massacesi, Jordi Rodón
Publié 2012Artigo -
16
Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601) par C. Decroisette, I. Monnet, H. Bérard, Gilles Quéré, H. Le Caer, Suzanna Bota, Clarisse Audigier-Valette, L. Gérinière, Jean-Marc Vernejoux, C. Chouaïd
Publié 2011Artigo -
17
Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study par J. Le Treut, M. C. Sault, H. Léna, P.-J. Souquet, A. Vergnenègre, H. Le Caer, H. Bérard, S. Boffa, I. Monnet, Diane Damotte, C. Chouaïd
Publié 2013Artigo -
18
Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC par Paul Lesueur, Alexandre Escande, Juliette Thariat, E. Vauléon, I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais
Publié 2018Artigo -
19
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy par Romain-David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, G. Bonardel, C. Chouaïd, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion
Publié 2021Artigo -
20
Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis par Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, Anne-Françoise Gaudin, John R. Penrod, V. Grumberg, B. Jouaneton, R. Jolivel, Jean‐Baptiste Assié, C. Chouaïd
Publié 2019Artigo
Outils de recherche:
Sujets similaires
Internal medicine
Medicine
Oncology
Cancer
Lung cancer
Chemotherapy
Immunotherapy
Biology
Surgery
Confidence interval
Hazard ratio
Nivolumab
Clinical endpoint
Gastroenterology
Cisplatin
Lung
Pathology
Randomized controlled trial
Cancer research
Cohort
Environmental health
Genetics
Adverse effect
Durvalumab
Gene
Paleontology
Population
Stage (stratigraphy)
COPD
Clinical trial